How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors’ associated rash?

Transcranial Direct Current Stimulation With Halo Sport Enhances Repeated Sprint Cycling and Cognitive Performance

The present study investigated the effects of transcranial direct current stimulation (tDCS) using the Halo Sport device on repeated sprint cycling ability and on cognitive performance. In this triple-blind, randomized, sham-controlled study, nine physically active participants received either a placebo stimulation (Sham) or real stimulation (Halo) for 20 min. Participants then performed 5 × 6-s sprints interspersed with 24 s of active recovery on a cycle ergometer. Peak and mean power output were measured for each sprint. In addition, cognitive performance in terms of reaction time (RT) and accuracy (ACC) was assessed via Stroop test pre- and post-stimulation. There was a significant interaction for mean power output [F(4,32) = 2.98, P = 0.03]. A main treatment effect was observed in all of the repeated sprints apart from the initial one. Halo did not affect RT in either the congruent or incongruent condition but did increase ACC in the incongruent condition [F(1,8) = 10.56, P = 0.012]. These results suggest that tDCS with the Halo Sport system is able to enhance aspects of sprint cycling ability and cognitive performance.

Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts

Chemotherapy and its cutaneous side effects are an increasingly common source of iatrogenic injury to the skin, hair, and nails. Cutaneous changes are among the most common side effects from treatment with particular targeted chemotherapeutic agents, especially those that target the epidermal growth factor receptor and small molecule multikinase inhibitors. Less common, but growing in recognition, are the development of secondary cutaneous neoplasms and subacute cutaneous lupus erythematosus as a result of chemotherapy. There is considerable overlap of the multiple entities described as a side effect from conventional chemotherapeutic agents; therefore, the term "toxic erythema of chemotherapy" can be used as an easily understood name.